Literature DB >> 29299700

Emergent spinal MRI in IVDU patients presenting with back pain: do we need an MRI in every case?

Charles G Colip1, Mina Lotfi2, Karen Buch2, Nagaraj Holalkere2, Bindu N Setty2.   

Abstract

PURPOSE: Spinal MRI is the exam of choice for the workup of patients with suspected spinal infection. In this retrospective study, we assess the value of obtaining contrast-enhanced spinal MRI for patients presenting to the emergency department (ED) with acute back pain and a history of intravenous drug use (IVDU).
METHODS: A retrospective IRB-approved, HIPAA compliant review of the imaging findings, reports and electronic charts of 167 consecutive IV drug-using patients (M/F = 96:71, mean age = 40 years) that presented to the ED with acute back pain over a 55-month period and underwent contrast-enhanced spinal MRI within 24 h. Fisher's exact test was used to identify statistically significant (p < 0.05) associations with MRI findings.
RESULTS: Evidence of infectious spondylitis was demonstrated on the spinal MRIs of 39.5% (n = 66) of 167 patients, all of whom were admitted, and nearly half (48.5%; 32/66) underwent surgical or percutaneous intervention. Statistically significant differences in the decision to admit, blood cultures, and the type of treatment was demonstrated in patients with findings of spinal infection on MRI (p < 0.05).
CONCLUSION: Use of emergent spinal MRI in the workup of IVDU patients with acute back pain is justified despite the resultant pressure on MRI scanner, technologist, and interpretation time.

Entities:  

Keywords:  Discitis; Epidural; IVDU; MRI; Osteomyelitis; Spine

Mesh:

Substances:

Year:  2018        PMID: 29299700     DOI: 10.1007/s10140-017-1572-9

Source DB:  PubMed          Journal:  Emerg Radiol        ISSN: 1070-3004


  58 in total

Review 1.  Spinal and spinal cord infection.

Authors:  Danielle L Balériaux; Carine Neugroschl
Journal:  Eur Radiol       Date:  2004-03       Impact factor: 5.315

Review 2.  Spinal epidural abscess presenting as intra-abdominal pathology: a case report and literature review.

Authors:  Andrew A Bremer; Rabih O Darouiche
Journal:  J Emerg Med       Date:  2004-01       Impact factor: 1.484

3.  The clinical use of magnetic resonance imaging in pyogenic vertebral osteomyelitis.

Authors:  E J Carragee
Journal:  Spine (Phila Pa 1976)       Date:  1997-04-01       Impact factor: 3.468

4.  MR appearances of the temporal evolution and resolution of infectious spondylitis.

Authors:  A R Gillams; B Chaddha; A P Carter
Journal:  AJR Am J Roentgenol       Date:  1996-04       Impact factor: 3.959

5.  Spinal epidural abscess: evaluation with gadolinium-enhanced MR imaging.

Authors:  Y Numaguchi; D Rigamonti; M I Rothman; S Sato; F Mihara; N Sadato
Journal:  Radiographics       Date:  1993-05       Impact factor: 5.333

6.  Cervical discitis associated with spinal epidural abscess caused by methicillin-resistant staphylococcus aureus.

Authors:  M Sawada; M Iwamura; T Hirata; N Sakai
Journal:  Neurol Med Chir (Tokyo)       Date:  1996-01       Impact factor: 1.742

Review 7.  Spinal infection.

Authors:  P N Tyrrell; V N Cassar-Pullicino; I W McCall
Journal:  Eur Radiol       Date:  1999       Impact factor: 5.315

Review 8.  Spinal infections.

Authors:  E Turgut Tali
Journal:  Eur J Radiol       Date:  2004-05       Impact factor: 3.528

9.  Vertebral osteomyelitis: assessment using MR.

Authors:  M T Modic; D H Feiglin; D W Piraino; F Boumphrey; M A Weinstein; P M Duchesneau; S Rehm
Journal:  Radiology       Date:  1985-10       Impact factor: 11.105

10.  Spinal infection in intravenous drug abusers.

Authors:  Chin-Yi Chuo; Yin-Chih Fu; Yen-Mou Lu; Jian-Chih Chen; Wun-Jer Shen; Chung-Hsien Yang; Cheng-Yen Chen
Journal:  J Spinal Disord Tech       Date:  2007-06
View more
  1 in total

1.  Demographics and Length of Stay for Osteomyelitis in Opioid Drug Users: A Unique Population with High Healthcare Costs.

Authors:  Eric Yuschak; Stacy Chase; Furqan Haq; Christian Vandever
Journal:  Cureus       Date:  2019-03-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.